~~<i id='1D05D78A75'><strike id='1D05D78A75'><tt id='1D05D78A75'><pre id='1D05D78A75'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

knowledge

author：hotspot 2025-09-03 03:29:49 - browse：13722

AP/Richard Drew

Johnson & Johnson said Monday that it would purchase Ambrx Biopharma for nearly $2 billion, picking up a company specializing in targeted chemotherapy treatments — one of the hottest areas of cancer drug development.

The deal, disclosed as the biopharma field marked the first day of the annual J.P. Morgan Healthcare Conference, extends a recent spate of pharma acquisitions, contributing to hopes that 2024 could be a better year for the industry.

Under the agreement, J&J will pay $28 per share in cash for Ambrx, roughly a 100% premium to the latter’s recent trading price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： Female surgeons have lower rates of long

hotspot

Wikipedia

hotspot

leisure time

hotspot

focus

AdobeAgrowingnumberofAItoolsarebeingusedtopredicteverythingfromsepsistostrokes,withthehopeofaccelera

WSS

Germany receives 178 compensation applications from gay servicepeople over discrimination

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Readout LOUD podcast: Merger Mondays, Ozempic panic

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

What's changing in Medicare's open enrollment this year?

Ohioans vote in high

hotspot

knowledge

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Germany receives 178 compensation applications from gay servicepeople over discrimination

BioMarin wins approval for gene therapy to treat hemophilia A

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Cancer drug shortages should be causing more outrage

Germany receives 178 compensation applications from gay servicepeople over discrimination

Guidelines to prevent youth baseball injuries need more muscle

Wellcome Trust names Røttingen as its new CEO

How one medical school became remarkably diverse

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Wikipedia

Eight reasons why you should get an updated Covid vaccine

STAT Readout: Today's biotech news includes Sana and Amylyx

Peter Marks talks Operation Warp Speed for Rare Diseases

CDC launches VaccineFinder tool to locate Covid

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

hotspot

leisure time

hotspot

focus